Home / Healthcare / Pharmaceutical / Female Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Report Format: PDF | Published Date: Oct, 2024 | Report ID: FBI100850 | Status : Published
  • Global
  • 2022
  • 131
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Buy Now

Healthcare Clients